WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattChairperson CEO2026-03-261,100$537.97
$591.77kSell
Martine A. RothblattChairperson CEO2026-03-261,476$535.06
$789.74kSell
Tommy G. ThompsonDirector2026-03-262,000$101.80
$203.60kBuy
Martine A. RothblattChairperson CEO2026-03-26740$538.90
$398.79kSell
Martine A. RothblattChairperson CEO2026-03-262,029$536.00
$1.09MSell
Martine A. RothblattChairperson CEO2026-03-26841$532.08
$447.48kSell
Tommy G. ThompsonDirector2026-03-26275$537.62
$147.85kSell
Tommy G. ThompsonDirector2026-03-261,414$539.25
$762.49kSell
Tommy G. ThompsonDirector2026-03-26311$540.18
$167.99kSell
Martine A. RothblattChairperson CEO2026-03-269,500$146.03
$1.39MBuy

1 of 122

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lilly Co Eli11.98%5,251,394$2.75BInsider
Blackrock Inc11.80%5,170,766$2.70BInstitution
Vanguard Group Inc9.53%4,176,016$2.18BInstitution
Avoro Capital Advisors LLC5.95%2,606,060$1.36BInstitution
Wellington Management Group LLP5.57%2,441,492$1.28BInstitution
Renaissance Technologies LLC4.36%1,909,259$998.22MInstitution
State Street Corp4.20%1,842,411$963.27MInstitution
Aqr Capital Management LLC2.92%1,281,699$670.11MInstitution
Geode Capital Management LLC2.72%1,193,064$623.77MInstitution
Martine A. Rothblatt2.00%878,455$459.28MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR86.81%13.19%Net SellingNet Selling
BNTX19.96%17.56%
MRNA77.07%22.51%Net BuyingNet Selling
RPRX61.89%17.28%Net SellingNet Selling
ROIV43.10%56.90%Net SellingNet Selling
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 95.27% institutional shareholders, 14.47% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.98% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.75B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.